Company Filing History:
Years Active: 2000-2024
Title: Peter Laing: Innovator in Pharmaceutical Formulations
Introduction
Peter Laing is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceutical formulations, holding a total of 7 patents. His work focuses on innovative drug release mechanisms and diagnostic methods related to flavivirus infections.
Latest Patents
Among his latest patents, Laing has developed controlled release pharmaceutical formulations. These formulations include drug release polymer compounds and compositions comprising prostacyclin compounds. Additionally, he has created glycosylated analogues of flavivirus E proteins, which are used in diagnostic methods for detecting anti-flavivirus antibodies and diagnosing flavivirus infections.
Career Highlights
Laing has worked with prominent companies in the pharmaceutical industry, including United Therapeutics Corporation and Excivion Ltd. His expertise in drug formulation and diagnostics has positioned him as a key player in the development of innovative medical solutions.
Collaborations
Laing has collaborated with notable professionals in his field, including Tony Johnson and Terrance Hart. These partnerships have contributed to the advancement of his research and the successful implementation of his inventions.
Conclusion
Peter Laing's contributions to pharmaceutical innovations highlight his role as a leading inventor in the industry. His patents and collaborations continue to influence advancements in drug delivery and diagnostic methods.